Nuvectra (NSDQ:NVTR) announced that it filed a voluntary petition for reorganization under Chapter 11 of the U.S. Bankruptcy Code. The Plano, Texas–based neurostimulation company filed the petition earlier this week in the U.S. Bankruptcy Court for the Eastern District of Texas. Nuvectra said it plans to use the court-supervised bankruptcy process to review its options […]
Minnetronix Medical picks president Jeremy Maniak as new CEO
Minnetronix Medical (St. Paul, Minn.) said today that current president Jeremy Maniak will take over as the company’s CEO in February 2020. The nine-year veteran of Minnetronix is slated to succeed the company’s founder Richard Nazarian. Nazarian founded Minnetronix in 1996 along with 3M veterans Dirk Smith and Jon Pierce, growing the medical device contract […]
BioSig lands $1M investment from Mayo Clinic
Cardiac arrhythmia-detection startup BioSig Technologies (NSDQ:BSGM) has received nearly $1 million in financing from the Mayo Clinic after working with the healthcare organization for two years. BioSig recently completed first-in-human studies at the Rochester, Minn.-based clinic aimed at validating the safety and efficacy of its Pure EP system during mapping and ablation procedures in a cardiac EP lab. Patient […]
DeviceTalks Boston: Here’s a sampling of exhibitors
Join the hundreds of people attending DeviceTalks Bostonthis week, and you’ll see dozens of exhibitors representing a strong sampling of the medical device supplier network supporting New England and the U.S. in general. Here are some examples of interesting exhibitors to see at the show>>
Minnetronix Neuro inks Neurapheresis Consortium deal with Duke
Minnetronix Medical’s Neuro division said today it joined with Duke University to co-found The Neurapheresis Consortium, which aims to accelerate the advancement of Neurapheresis Therapy intended to treat patients with diseases affecting the central nervous system. The company’s Neurapheresis therapy system is a minimally invasive platform which includes a dual lumen catheter designed to be […]
Minnetronix touts completion of Neurapheresis hemorrhagic stroke trial
Minnetronix’s Neuro division said today they completed the first trial of its Neurapheresis Therapy system exploring its use in treating patients suffering from aneurysmal subarachnoid hemorrhage. The company’s Neurapheresis Therapy system is a minimally invasive platform which includes a dual lumen catheter designed to be placed in the lumbar spine to filter contaminated cerebral spinal […]
Minnetronix rebrands, eyes neuro market
Minnetronix said today that it’s adding “Medical” to its name, unveiling a new corporate look to emphasize its focus on the neurocritical care market. Founded in 1996, the St. Paul, Minn.-based company said it’s developing a line of devices for the neurological ICU, beginning with the Neurapheresis device for treating post-aneurysmal subarachnoid hemorrhage. A first-in-human study is already […]
Medtronic expands paid family leave benefits for US employees | Personnel Moves – May 1, 2018
Medtronic (NYSE:MDT) today announced expanded paid family leave benefits which the company says will “allow for greater employee flexibility while balancing work and family priorities.” The new benefits, which went into effect today, cover full and part-time US employees and allow for a “wide range of family care leave needs,” the Fridley, Minn.-based company said. These […]
How and when to outsource product development
Sometimes, it makes sense for a medtech company to outsource product development to bring their device to market faster and more efficiently. MassDevice.com editor Sarah Faulkner spoke to Minnetronix‘s VP of business development and marketing, Jim Reed, about how and when medtech companies should consider outsourcing product development to a partner. Faulkner: How should companies […]
Early collaboration is key in drug-device development, experts say
While pharmaceutical companies and medical device firms know that working together is a vital part of doing business, they “live in 2 different world in many ways,” Minnetronix co-founder Dirk Smith said last week at the annual Drug Delivery Partnerships conference. From development timelines to regulatory approval pathways, it can sometimes seem like pharma and medtech companies are […]
BioSig taps Minnetronix to develop Pure EP prototype
BioSig Technologies (OTCQB: BSGM) issued a letter to its shareholders today, updating them on the company’s recent developments and revealing that it tapped Minnetronix to develop the 1st version of its Pure EP system. The Minneapolis-based company is developing a cardiac signal acquisition and display system which is designed to assist electrophysiologists in making clinical decisions for patients with […]
